Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kamakshi Zeidler

Plastic Surgery Campbell, CA Medical Doctor

NPI 1285766220 CMS profile 284886

3803 S Bascom Ave, Ste 100, Campbell, CA 95008

Open in the dashboard

General payments

$237,361

213 records reported · program years 2019–2025

Research payments

$5,500

Paid to them · 13 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,250 paid to institutions, not to them · program year 2020

Through program year 2025, Kamakshi Zeidler of Campbell, CA is reported in the CMS Open Payments database as having received $237,361 across 213 general payments and $5,500 in research payments paid to them. Separately, studies naming them as principal investigator received $3,250 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $80,607 45
2024 General $95,428 34
2023 General $19,618 31
2022 General $12,201 34
2022 Research $1,750 1
2021 General $1,339 17
2021 Research $1,000 1
2020 General $15,179 23
2019 General $12,989 29
2019 Research $2,750 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kamakshi Zeidler
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Kamakshi Zeidler were reported at $80,607. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Kamakshi Zeidler Plastic Surgery median Middle half National median
2019 $12,989 $371 $122–$1,483 $163
2020 $15,179 $158 $52–$438 $114
2021 $1,339 $249 $87–$752 $132
2022 $12,201 $274 $102–$793 $149
2023 $19,618 $299 $113–$891 $160
2024 $95,428 $361 $124–$1,062 $164
2025 $80,607 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Motiva USA, LLC $95,289 33 payments
  2. Bimini Technologies LLC $55,225 5 payments
  3. Allergan Inc. $31,268 62 payments
  4. AbbVie, Inc. $20,383 50 payments
  5. Integra LifeSciences Corporation $18,768 21 payments
  6. Musculoskeletal Transplant Foundation Inc. $4,685 9 payments
  7. Sientra, Inc. $4,309 21 payments
  8. Tepha Inc $3,619 4 payments
  9. Galderma Laboratories, L.P. $3,058 4 payments
  10. C. R. Bard, Inc. & Subsidiaries $650 1 payment
  11. Other $108 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $187,217 29 payments
  2. Travel and Lodging $39,590 35 payments
  3. Food and Beverage $7,634 136 payments
  4. Education $2,583 11 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $250 1 payment
  6. Gift $87 1 payment
Products named General payments · program years 2019–2025
  1. Motiva Implant Matrix Plastic Surgery $90,358 8 payments
  2. Integra $13,509 11 payments
  3. OMNIGRAFT $12,982 6 payments
  4. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $9,574 14 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $8,148 9 payments
  6. BOTOX COSMETIC $7,791 10 payments
  7. Motiva Implant Matrix Devices $4,736 23 payments
  8. SURGIMEND $4,453 4 payments
  9. CODMAN CERTAS $4,400 2 payments
  10. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $4,309 21 payments
  11. Other $18,180 94 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sientra, Inc. $5,500 13 payments

Records

226 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record